thiodigalactoside has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, S; Astorgues-Xerri, L; Faivre, S; Neuzillet, C; Raymond, E; Riveiro, ME; Serova, M; Tijeras-Raballand, A | 1 |
| Bratman, SV; Chan, C; Diehn, M; Giaccia, AJ; Gupta, A; Koong, AC; Kuo, P; Le, QT; Loo, BW; Say, C; Shultz, DB; von Eyben, R; Wang, Z | 1 |
| Blanchard, H; Cutler, S; Dong, LF; Ito, K; Neuzil, J; Ralph, SJ; Scott, SA | 1 |
| Blanchard, H; Clark, AM; Gabutero, E; Ito, K; Neo, SY; Onturk, S; Ralph, SJ; Stannard, K | 1 |
2 review(s) available for thiodigalactoside and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Unraveling galectin-1 as a novel therapeutic target for cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Calixarenes; Galectin 1; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Peptides; Signal Transduction; Thiogalactosides; Up-Regulation | 2014 |
Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.
Topics: Animals; Cell Hypoxia; Galectin 1; Humans; Immune Tolerance; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; T-Lymphocytes; Thiogalactosides; Tumor Microenvironment | 2012 |
2 other study(ies) available for thiodigalactoside and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.
Topics: Animals; Apoptosis; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Galectin 1; Humans; Lung Neoplasms; Lymphopenia; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Thiogalactosides | 2014 |
Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.
Topics: Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Resistance, Neoplasm; Endothelial Cells; Female; Galectin 1; Gene Knockdown Techniques; Immunity, Cellular; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Oxidative Stress; Thiogalactosides | 2011 |